EPISODE · Apr 3, 2023 · 10 MIN
Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment
Embed this episode
What this episode covers
Visit https://www.peervoice.com/BAC860 to view the entire programme with slides. After completing “Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment”, participants will be able to: Evaluate long-term data with novel agents used for continuous or fixed-duration treatment (FDT) regimens in chronic lymphocytic leukemia (CLL); Assess patient risk level, incorporating cytogenetics, age, and other key considerations; and Discuss CLL treatment approach based on patient risk level.
Ready to play
Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment
No transcript for this episode yet
Similar Episodes
No similar episodes found.